Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Impact on CAC Density in CAD Patients with Diabetes
NCT02418884Phase 4Unknown
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Apr 2015
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of rosuvastatin in coronary artery disease (CAD), sponsored by Sir Run-Run Shaw Hospital. Status: unknown.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02418884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418884.